GenSight Biologics S.A. (GSGTF)
OTCMKTS
· Delayed Price · Currency is USD
0.2400
-0.0800 (-25.00%)
At close: Dec 31, 2024
GenSight Biologics Employees
GenSight Biologics had 16 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
16
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$169,855
Profits / Employee
-$905,956
Market Cap
30.31M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
CytoDyn | 9 |
Glass House Brands | 374 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
GenSight Biologics News
- 22 days ago - GenSight Biologics Annual General Meeting on May 13, 2025 - Business Wire
- 5 weeks ago - GenSight Biologics Announces the Filing of its 2024 Universal Registration Document - Business Wire
- 5 weeks ago - GenSight Biologics Reports Cash Position as of March 31, 2025, and Provides Business Update - Business Wire
- 2 months ago - GenSight Biologics Confirms Definitive Full-Year 2024 Consolidated Financial Results Are in Line with Estimates - Business Wire
- 2 months ago - GenSight Biologics Announces LUMEVOQ® Scientific Updates at NANOS 2025 - Business Wire
- 2 months ago - GenSight Biologics S.A. reports FY results - Seeking Alpha
- 2 months ago - GenSight Biologics Reports Estimated Full-Year 2024 Consolidated Financial Results - Business Wire
- 3 months ago - GenSight Biologics Announces Five-Year Efficacy and Safety Results for LUMEVOQ® Gene Therapy at the Conclusion of the REFLECT Study - Business Wire